ALLIED HEALTHCARE PRODUCTS INC | 1,836 Euro | -0,075 -3,92 % | |
| WKN: 883319 ISIN: US0192221085 Ticker-Symbol: AWI | Berlin | 24.05.13 | 08:08 Uhr |
Branche GesundheitswesenAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 10.05. | Allied Healthcare Products Reports Loss On Depressed Sales | 37 | PR Newswire | |
| ST. LOUIS, May 10, 2013 /PRNewswire/ -- The continuing recession in domestic hospital equipment and a dip in international sales resulted in a loss for Allied Healthcare Products (NASDAQ:... Mehr lesen zu: Allied Healthcare Products Reports Loss On Depressed Sales | ||||
| 11.02. | Allied Healthcare Products Reports Second Quarter Loss | 41 | PR Newswire | |
| ST. LOUIS, Feb. 11, 2013 /PRNewswire/ -- With governmental markets at all levels coping with severe budget constraints, and hospital equipment markets also in recession, Allied Healthcare... Mehr lesen zu: Allied Healthcare Products Reports Second Quarter Loss | ||||
| 11.02. | ALLIED HEALTHCARE PRODUCTS INC - 10-Q, Quarterly Report | - | SEC Filings | |
| 07.11. | Allied Healthcare Reports First Quarter Loss | 30 | PR Newswire | |
| ST. LOUIS, Nov. 7, 2012 /PRNewswire/ -- Allied Healthcare Products, Inc., (NASDAQ: AHPI) reported a loss for the first quarter with sales that continue to be dampened by a restrained economy and uncertainties... Mehr lesen zu: Allied Healthcare Reports First Quarter Loss | ||||
| 28.09. | Allied Healthcare Reports Loss On Depressed Sales | 44 | PR Newswire | |
| ST. LOUIS, Sept. 28, 2012 /PRNewswire/ -- Allied Healthcare Products, Inc., (NASDAQ: AHPI) reported a loss for the fourth quarter and fiscal year on sales depressed by the lingering effects of recession... Mehr lesen zu: Allied Healthcare Reports Loss On Depressed Sales | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| FRESENIUS MEDICAL CARE | 53,09 | -0,95 % | Fresenius Medical Care: Aktienrückkauf beginnt heute |
| FRESENIUS | 94,50 | -0,89 % | Fresenius-Aktie: Übernahmeschlacht mit Asklepios um RHÖN-KLINIKUM doch noch nicht verloren? |
| RHOEN-KLINIKUM | 16,25 | -0,25 % | Commerzbank belässt Rhön-Klinikum auf 'Buy' - Ziel 20,50 Euro |
| DRAEGERWERK | 96,35 | -1,01 % | DGAP-DD: Drägerwerk AG & Co. KGaA (deutsch) |
| CARL ZEISS MEDITEC | 24,50 | +0,45 % | 19. Mai Vintage: Carl-Zeiss, Buick, Post, GNU |
